| The COVID‐19 Severity and Its Association with Intestinal Parasite Coinfection and Urine Biochemical Parameters among COVID‐19‐Confirmed Patients Admitted to Debre Markos … M Toru, A Atnaf, HM Mengist, A Reta BioMed Research International 2024 (1), 3064374, 2024 | | 2024 |
| In silico Screening of Potential SARS-CoV-2 Main Protease Inhibitors from Thymus schimperi HM Mengist, Z Khalid, F Adane Advances and Applications in Bioinformatics and Chemistry, 1-13, 2023 | | 2023 |
| Prevalence, antimicrobial resistance pattern, and associated factors of Salmonella and Shigella among under five diarrheic children attending public health … M Dessale, G Mengistu, HM Mengist Frontiers in Public Health 11, 1114223, 2023 | 4 | 2023 |
| Aging, inflammaging and immunosenescence as risk factors of severe COVID-19 AM Tizazu, HM Mengist, G Demeke Immunity & Ageing 19 (1), 53, 2022 | 44 | 2022 |
| Bacterial isolates, their antimicrobial susceptibility pattern, and associated factors of external ocular infections among patients attending eye clinic at Debre Markos … Z Haile, HM Mengist, T Dilnessa Plos one 17 (11), e0277230, 2022 | 13 | 2022 |
| Prevalence of medication non-adherence and associated factors among diabetic patients in a tertiary hospital at Debre Markos, Northwest Ethiopia Y Mitiku, A Belayneh, BA Tegegne, B Kebede, D Abebe, Y Biyazin, ... Ethiopian Journal of Health Sciences 32 (4), 755-764, 2022 | 7 | 2022 |
| Prevalence, Antibiogram, and Associated Factors of Bacteria Isolated From Presumptive Meningitis Patients at Debre Markos Comprehensive Specialized Hospital, Northwest Ethiopia Z Hibstu, A Mullu, A Mihret, HM Mengist Cureus 14 (8), 2022 | | 2022 |
| IgNAR antibody: Structural features, diversity and applications Z Khalid, Y Chen, D Yu, M Abbas, M Huan, Z Naz, HM Mengist, M Cao, ... Fish & Shellfish Immunology 121, 467-477, 2022 | 15 | 2022 |
| SARS-CoV-2 subunit vaccine adjuvants and their signaling pathways D Mekonnen, HM Mengist, T Jin Expert Review of Vaccines 21 (1), 69-81, 2022 | 30 | 2022 |
| Phage therapy: a different approach to fight bacterial infections Z Hibstu, H Belew, Y Akelew, HM Mengist Biologics: Targets and Therapy, 173-186, 2022 | 27 | 2022 |
| Nanotechnology: a promising approach for cancer diagnosis, therapeutics and theragnosis M Dessale, G Mengistu, HM Mengist International Journal of Nanomedicine 17, 3735, 2022 | 60 | 2022 |
| Immune Evasion by the Highly Mutated SARS-CoV-2 Omicron Variant HM Mengist, JA Kombe Kombe, T Jin Infection and Drug Resistance, 4013-4027, 2022 | 2 | 2022 |
| Generation, biochemical characterizations and validation of potent nanobodies derived from alpaca specific for human receptor of advanced glycation end product A Mohammed, W Zeng, HM Mengist, AJK Kombe, H Ou, Y Yang, Z Dan, ... Biochemical and Biophysical Research Communications 581, 38-45, 2021 | 2 | 2021 |
| Epidemiological, Clinical and Laboratory Characteristics of Patients with Brucella Infection in Anhui Province, China C Shi, L Wang, D Lv, G Wang, HM Mengist, T Jin, B Wang, Y Huang, Y Li, ... Infection and drug resistance, 2741-2752, 2021 | 16 | 2021 |
| Mutations of SARS-CoV-2 spike protein: Implications on immune evasion and vaccine-induced immunity HM Mengist, AJK Kombe, D Mekonnen, A Abebaw, M Getachew, T Jin Seminars in immunology 55, 101533, 2021 | 101 | 2021 |
| Effects of intestinal parasite infection on hematological profiles of pregnant women attending antenatal care at Debre Markos Referral Hospital, Northwest Ethiopia: Institution … G Demeke, G Mengistu, A Abebaw, M Toru, M Yigzaw, A Shiferaw, ... PloS one 16 (5), e0250990, 2021 | 14 | 2021 |
| Diagnostic accuracy of serological tests and kinetics of severe acute respiratory syndrome coronavirus 2 antibody: A systematic review and meta‐analysis D Mekonnen, HM Mengist, A Derbie, E Nibret, A Munshea, H He, B Li, ... Reviews in medical virology 31 (3), e2181, 2021 | 85 | 2021 |
| Structural basis of potential inhibitors targeting SARS-CoV-2 main protease HM Mengist, T Dilnessa, T Jin Frontiers in Chemistry 9, 622898, 2021 | 267 | 2021 |
| Structural basis of the pore-forming toxin/membrane interaction Y Li, Y Li, HM Mengist, C Shi, C Zhang, B Wang, T Li, Y Huang, Y Xu, ... Toxins 13 (2), 128, 2021 | 36 | 2021 |
| Potency, safety, and pharmacokinetic profiles of potential inhibitors targeting SARS-CoV-2 main protease HM Mengist, D Mekonnen, A Mohammed, R Shi, T Jin Frontiers in pharmacology 11, 630500, 2021 | 35 | 2021 |
Daniel Mekonnen (PhD)Bahir Dar University在 bdu.edu.et 的电子邮件经过验证
